Bvgh engages biopharmaceutical companies in programs, partnerships and initiatives that solve global health problems.

Health

Is a global consortium founded by bvgh, the world intellectual property organization (wipo) and leading pharmaceutical companies. The aim of the consortium is to accelerate the development of new drugs, vaccines, and diagnostics for neglected tropical diseases (ntds), malaria, and tuberculosis through the sharing of intellectual property (ip). the african access initiative (aai) is a partnership of companies, governments, healthcare providers, and ngos focused on sustainably expanding access to cancer medicines and technologies, improving healthcare infrastructure, and building clinical and r&d capacity in africa. africa pavilion: programming at the annual bio international convention to showcase african r&d innovations and foster international partnerships bvgh engages in various activities around capacity building in low and middle income countries (lmics). Bvgh coordinates and manages the placement of industry and academic scientists at lmic institutes, as well as lmic researchers at companies and universities, for short-term research fellowships and sabbaticals. The fellowship experience provides an invaluable opportunity to gain the knowledge, skills, and relationships that can transform careers and advance research. In addition, bvgh places gently used laboratory equipment sourced from biopharmaceutical companies at research institutions in lmics to enhance in-country r&d capabilities.